C. Duran et al., Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: Partial retention of a pluripotent phenotype, INT J CANC, 93(3), 2001, pp. 324-332
To investigate whether the failure of human EC cells that do not differenti
ate is due to the loss of key differentiation-permissive functions or the a
cquisition of specific inhibitory functions, we tested the ability to diffe
rentiate of 2 hybrids produced between a relatively nullipotent human EC ce
ll line, 2102Ep, and a pluripotent human EC cell line NTERA2, Both hybrids,
which exhibited an EC phenotype, were able to differentiate readily in res
ponse to retinoic acid. Furthermore, 1 hybrid produced a well-differentiate
d xenograft tumor, which contained, like the NTERA2 tumors, glandular struc
tures, loose mesenchymal tissues and nodules of cartilage, after injection
into a SCID mouse. Thus, the failure of 2102Ep EC cells to differentiate is
recessive and due to the loss of a key gene function or functions. Neverth
eless, the hybrids differed from the pluripotent NTERA2 line by failing to
differentiate in neurons, indicating that 2102Ep cells also had acquired a
specific, dominantly-acting, inhibitory mutation specific to the neural lin
eage. Furthermore, the expression of collagen II by one hybrid before and a
fter induction with retinoic: suggested a propensity for spontaneous differ
entiation not evident in the parental NTERAZ cells. Thus, the mechanisms th
at restrict the differentiation capacity of the nullipotent 2102Ep line are
complex and include both recessive and dominant acting factors. (C) 2001 W
iley-Liss, Inc.